![Life-sciences-healthcare-medicine-doctor-consult-AdobeStock_204066372](https://www.nortonrosefulbright.com/-/media/images/nrf/hero/life-sciences-healthcare-medicine-doctor-consult-adobestock_204066372.jpg?w=265&revision=2c8471a9-a0c6-4b1c-8320-4d1f3713a015&revision=5250222615397387904&hash=256FF231E0B62A2ABB3C5CF799F81CAB)
Publication
TGA shelves biosimilar and generic transparency measures
In late 2020, following almost 18 months of public and industry consultations conducted by the Therapeutic Goods Administration (TGA).
Global | Publication | April 2020
On April 8, 2020, the European Commission published a communication setting out a temporary framework for analyzing agreements entered into between competitors whose purpose is to address the urgent needs arising from the health crisis (the Temporary Framework).
You will find below a summary of the main points of this Temporary Framework, which are also analyzed in light of the principles resulting from:
We also provide you with an operational tool allowing a preliminary analysis of such cooperation agreements.
Publication
In late 2020, following almost 18 months of public and industry consultations conducted by the Therapeutic Goods Administration (TGA).
Publication
The NSW Environment Protection Authority (EPA) recently released for public comment its draft Climate Change Assessment Requirements (CCARs) and draft Guide for Large Emitters (Guide).
Publication
The introduction of a minimum stockholding obligation under the Fuel Security Act 2021 (Cth) has underscored the importance of traditional liquid fuels to safeguarding Australia’s energy security as it navigates the energy transition.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023